Table 3

ECG characteristics of paediatric athletes: impact of age

Characteristics ≥14 years <14 years % Difference
PR interval (ms)151 (140–162)
(4; 1985) (99%)
142 (137147)
(4; 89) (58%)
6
QRS duration (ms)92 (9193)*
(4; 1991) (59%)
74 (7082)
(3; 77) (88%)
9
QTc duration (ms)377 (354–400)
(5; 4205) (99%)
394 (375412)
(3; 77) (6%)
−5
QRS axis* (°)76 (73–78)
(4; 2816) (89%)
74.7 (61.4–88.0)
(2; 63) (75%)
2
Group 1 ECG patterns OR
Sinus bradycardia (%)61.3 (46.3–75.3)
(5; 4205) (98%)
18.8 (12.1–26.7)
(2; 109) (0%)
6.6 (4.1–10.7)
LVH (%)48.0 (36.4–59.5)
(5; 4205) (98%)
20.7 (9.3–35.1)
(2; 109) (30%)
3.4 (2.2–5.5)
Group 2 ECG patterns Risk ratio
TWI (≥1 mm) (%)6.9 (3.7–10.9)
(6; 5051) (96%)
5.4 (0.2–16.9)
(2; 1272) (92%)
1.3 (1.0–1.7)
Anterior (%)5.4 (1.4–11.8)
(7; 6575) (98%)
6.7 (4.4–9.4)
(3; 2516) (78%)
1.2 (1.0–1.5)
Extended anterior (%)1.7 (0.4–4.0)*
(4; 3823) (94%)
0.5 (0.1–3.0)
(2; 1257) (68%)
3.1 (1.4–6.6)
Inferolateral (%)2.5 (1.0–4.6)
(5; 3710) (89%)
0.1 (0.01–0.4)
(2; 1272) (0%)
15.8 (3.9–63.9)
  • Data are presented as mean or percentage (95% CI) (number of articles; number of participants) (heterogeneity).

  • *p≤0.01, significantly greater or more prevalent in athletes≥14 years than in athletes <14 years.

  • p≤0.001, significantly greater or more prevalent in athletes≥14 years than in athletes <14 years.

  • ≤0.05, significantly greater or more prevalent in athletes<14 years than in athletes ≥14 years.

  • Anterior: V1–V3; extended anterior: V1–V4; inferolateral: leads II-aVF/V4-V6/I-aVL; NC, non-computable; LVH, left ventricular hypertrophy; TWI, T-wave inversion.